Free Trial
→ Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad) Free XTLB Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.

XTL Biopharmaceuticals (XTLB) Short Interest Ratio & Short Volume

Compare

XTL Biopharmaceuticals Short Interest Data

XTL Biopharmaceuticals (XTLB) has a short interest of 213,400 shares. This marks a 2,381.40% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.4, indicating that it would take 5.4 days of the average trading volume of 113,494 shares to cover all short positions.

Current Short Interest
213,400 shares
Previous Short Interest
8,600 shares
Change Vs. Previous Month
+2,381.40%
Dollar Volume Sold Short
$475,882.00
Short Interest Ratio
5.4 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
5,450,000 shares
Percentage of Shares Shorted
3.92%
Today's Trading Volume
21,333 shares
Average Trading Volume
113,494 shares
Today's Volume Vs. Average
19%
Short Selling XTL Biopharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for XTL Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

XTLB Short Interest Over Time

XTLB Days to Cover Over Time

XTLB Percentage of Float Shorted Over Time

XTL Biopharmaceuticals Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024213,400 shares $475,882.00 +2,381.4%N/A5.4 $2.23
10/15/20248,600 shares $19,092.00 -41.5%N/A1 $2.22
9/30/202414,700 shares $35,574.00 +51.6%N/A1.4 $2.42
9/15/20249,700 shares $25,501.30 +1.0%N/A0.9 $2.63
8/31/20249,600 shares $26,784.00 -7.7%N/A0.6 $2.79
8/15/202410,400 shares $29,016.00 +103.9%N/A0.6 $2.79
7/31/20245,100 shares $14,688.00 -64.3%N/A0.3 $2.88
7/15/202414,300 shares $35,607.00 -19.2%N/A0.8 $2.49
6/30/202417,700 shares $43,011.00 +78.8%N/A0.8 $2.43
6/15/20249,900 shares $20,196.00 -55.0%N/A0 $2.04
5/31/202422,000 shares $57,200.00 -13.4%N/A0 $2.60
5/15/202425,400 shares $69,596.00 +13.4%N/A0 $2.74
4/30/202422,400 shares $57,792.00 -62.8%N/A0 $2.58
4/15/202460,200 shares $161,336.00 -86.2%N/A0.1 $2.68
3/31/2024437,200 shares $1.23 million +21,760.0%N/A0.6 $2.81
3/15/20242,000 shares $1,760.00 +11.1%N/A0 $0.88
2/29/20241,800 shares $1,531.26 -37.9%N/A0.6 $0.85
2/15/20242,900 shares $2,608.26 -42.0%N/A0.9 $0.90
1/31/20245,000 shares $4,378.50 -27.5%N/A1.4 $0.88
1/15/20246,900 shares $6,009.90 +1.5%N/A1.9 $0.87
12/31/20236,800 shares $6,868.68 -32.7%N/A1.7 $1.01
12/15/202310,100 shares $9,965.67 -15.8%N/A3.9 $0.99
11/30/202312,000 shares $12,360.00 +36.4%N/A5.7 $1.03
11/15/20238,800 shares $6,864.00 -24.8%N/A2.7 $0.78
10/31/202311,700 shares $10,148.58 +62.5%N/A3.2 $0.87
10/15/20237,200 shares $6,480.00 -22.6%N/A1.3 $0.90
9/30/20239,300 shares $8,347.68 -3.1%N/A1.7 $0.90
9/15/20239,600 shares $9,311.04 +29.7%N/A1.5 $0.97
8/31/20237,400 shares $7,770.00 +236.4%N/A0.5 $1.05
8/15/20232,200 shares $2,086.26 +29.4%N/A0.2 $0.95
7/31/20231,700 shares $1,385.84 -19.1%N/A0.1 $0.82
7/15/20232,100 shares $2,142.00 -16.0%N/A0.1 $1.02
6/30/20232,500 shares $2,376.75 -28.6%N/A0.2 $0.95
6/15/20233,500 shares $4,620.00 -25.5%N/A0.2 $1.32
5/31/20234,700 shares $5,734.00 +27.0%N/A0.6 $1.22
5/15/20233,700 shares $4,477.00 +23.3%N/A0.5 $1.21
4/30/20233,000 shares $3,360.00 -55.2%N/A0.5 $1.12
4/15/20236,700 shares $8,241.00 -23.0%N/A1.7 $1.23
3/31/20238,700 shares $11,049.00 +117.5%N/A4.1 $1.27
3/15/20234,000 shares $4,920.00 +2.6%N/A1.6 $1.23
“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!
2/28/20233,900 shares $5,459.61 -7.1%N/A1.3 $1.40
2/15/20234,200 shares $5,586.00 -16.0%N/A1.5 $1.33
1/31/20235,000 shares $5,850.00 -12.3%N/A1.4 $1.17
1/15/20235,700 shares $7,866.00 +2,750.0%N/A1.7 $1.38
12/30/2022200 shares $242.00 -95.7%N/A0.1 $1.21
12/15/20224,700 shares $5,687.00 -6.0%N/A1 $1.21
11/30/20225,000 shares $6,650.00 +6.4%N/A1.2 $1.33
11/15/20224,700 shares $6,674.00 +261.5%N/A1 $1.42
10/31/20221,300 shares $1,677.00 -40.9%N/A0.3 $1.29
10/15/20222,200 shares $2,651.00 +83.3%N/A0.3 $1.21
9/30/20221,200 shares $1,332.00 -77.4%N/A0.2 $1.11
9/15/20225,300 shares $7,155.00 -22.1%N/A0.9 $1.35
8/31/20226,800 shares $10,064.00 +4.6%N/A1.2 $1.48
8/15/20226,500 shares $11,115.00 +8.3%N/A1.2 $1.71
7/31/20226,000 shares $9,780.00 -25.9%N/A1.1 $1.63
7/15/20228,100 shares $12,231.00 +42.1%N/A2.9 $1.51
6/30/20225,700 shares $8,664.00 +11.8%N/A1.7 $1.52
6/15/20225,100 shares $7,854.00 -13.6%N/A1.5 $1.54
5/31/20225,900 shares $10,714.99 -37.2%N/A0.9 $1.82
5/15/20229,400 shares $15,886.00 +20.5%N/A1.5 $1.69
4/30/20227,800 shares $17,160.00 +9.9%N/A1.4 $2.20
4/15/20227,100 shares $16,685.00 +16.4%N/A1.2 $2.35
3/31/20226,100 shares $14,457.00 +96.8%N/A0.9 $2.37
3/15/20223,100 shares $6,616.95 +121.4%N/A0.3 $2.13
2/28/20221,400 shares $3,332.00 -17.7%N/A0.1 $2.38
2/15/20221,700 shares $4,114.00 No ChangeN/A0.1 $2.42
1/31/20221,700 shares $4,284.00 -56.4%N/A0.1 $2.52
1/15/20223,900 shares $11,349.00 -17.0%N/A0.1 $2.91
12/31/20214,700 shares $13,019.00 +147.4%N/A0.2 $2.77
12/15/20211,900 shares $5,567.00 -64.2%N/A0.1 $2.93
11/30/20215,300 shares $16,960.00 +960.0%N/A0.2 $3.20
11/15/2021500 shares $1,790.00 -58.3%N/A0 $3.58
10/29/20211,200 shares $4,584.00 -60.0%N/A0 $3.82
10/15/20213,000 shares $11,790.00 -85.2%N/A0 $3.93
9/30/202120,200 shares $88,476.00 +1.0%N/A0.1 $4.38
9/15/202120,000 shares $82,800.00 -68.7%N/A0.1 $4.14
8/31/202163,900 shares $316,305.00 +75.6%N/A0.4 $4.95
8/13/202136,400 shares $129,220.00 -15.7%N/A0.3 $3.55
7/30/202143,200 shares $151,200.00 +37.6%N/A0.5 $3.50
7/15/202131,400 shares $108,958.00 -35.3%N/A0.4 $3.47
6/30/202148,500 shares $193,515.00 +40.2%N/A3.4 $3.99
6/15/202134,600 shares $119,370.00 -2.8%N/A2.1 $3.45
5/28/202135,600 shares $125,682.24 +14.8%N/A1.5 $3.53
5/14/202131,000 shares $103,230.00 -19.7%N/A0.1 $3.33
4/30/202138,600 shares $137,416.00 -5.6%N/A0.1 $3.56
4/15/202140,900 shares $132,516.00 -1.2%N/A0.2 $3.24
3/31/202141,400 shares $136,206.00 -19.8%N/A0.2 $3.29
3/15/202151,600 shares $174,924.00 +719.1%N/A0.2 $3.39
2/26/20216,300 shares $19,152.00 -77.7%N/A0 $3.04
2/12/202128,200 shares $106,596.00 +464.0%N/A1 $3.78
“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!
1/29/20215,000 shares $16,100.00 -76.5%N/A0.2 $3.22
1/15/202121,300 shares $84,135.00 +88.5%N/A0.8 $3.95
12/31/202011,300 shares $35,764.50 -76.6%N/A0.4 $3.17
12/15/202048,200 shares $126,766.00 +518.0%N/A2.5 $2.63
11/30/20207,800 shares $19,573.32 -34.5%N/A0.5 $2.51
10/30/20206,900 shares $15,318.00 -46.1%N/A0.4 $2.22
10/15/202012,800 shares $27,904.00 -14.1%N/A0.7 $2.18
9/30/202014,900 shares $28,308.51 +156.9%N/A0.9 $1.90
9/15/20205,800 shares $12,586.00 +65.7%N/A0.3 $2.17
8/31/20203,500 shares $5,950.00 +483.3%N/A0.1 $1.70
8/14/2020600 shares $1,032.00 -45.5%N/A0 $1.72
7/31/20201,100 shares $1,732.50 -93.3%N/A0.1 $1.58
7/15/202016,400 shares $25,060.84 +198.2%N/A0.9 $1.53
6/30/20205,500 shares $8,525.00 -16.7%N/A0.3 $1.55
6/15/20206,600 shares $9,075.00 -7.0%N/A0.4 $1.38
5/29/20207,100 shares $9,744.75 -47.0%N/A2.1 $1.37
5/15/202013,400 shares $18,626.00 -19.3%N/A2.7 $1.39
4/30/202016,600 shares $20,160.70 -3.5%N/A2.8 $1.21
4/15/202017,200 shares $19,780.00 -1.7%N/A2.4 $1.15
3/31/202017,500 shares $20,562.50 +10.1%N/A2 $1.18
3/13/202015,900 shares $16,536.00 +1.9%N/A1.7 $1.04
2/28/202015,600 shares $15,600.00 -7.7%N/A1.4 $1.00
2/14/202016,900 shares $18,083.00 -17.6%N/A1.8 $1.07
1/31/202020,500 shares $28,700.00 -3.3%N/A2.6 $1.40
1/15/202021,200 shares $30,740.00 +40.4%N/A3.5 $1.45
12/31/201915,100 shares $19,781.00 No ChangeN/A2.7 $1.31

XTLB Short Interest - Frequently Asked Questions

What is XTL Biopharmaceuticals' current short interest?

Short interest is the volume of XTL Biopharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 213,400 shares of XTLB short. Learn More on XTL Biopharmaceuticals' current short interest.

What is a good short interest ratio for XTL Biopharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XTLB shares currently have a short interest ratio of 5.0. Learn More on XTL Biopharmaceuticals's short interest ratio.

Is XTL Biopharmaceuticals' short interest increasing or decreasing?

XTL Biopharmaceuticals saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 213,400 shares, an increase of 2,381.4% from the previous total of 8,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does XTL Biopharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to XTL Biopharmaceuticals: DURECT Co. (3.35%), FibroGen, Inc. (4.29%), Fortress Biotech, Inc. (11.97%), Lantern Pharma Inc. (2.06%), Daré Bioscience, Inc. (0.35%), CalciMedica, Inc. (1.36%), Lexaria Bioscience Corp. (1.72%), Clene Inc. (2.91%), Lumos Pharma, Inc. (1.54%), BioLineRx Ltd. (1.33%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short XTL Biopharmaceuticals stock?

Short selling XTLB is an investing strategy that aims to generate trading profit from XTL Biopharmaceuticals as its price is falling. XTLB shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against XTL Biopharmaceuticals?

A short squeeze for XTL Biopharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of XTLB, which in turn drives the price of the stock up even further.

How often is XTL Biopharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XTLB, twice per month. The most recent reporting period available is October, 31 2024.



Related Companies
Short Interest Tools

This page (NASDAQ:XTLB) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
There is a little known company that is changing warfare
With geo - political instability around the world investors are flocking to defense contract stocks. There...
Reticulate | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
The pin that pops the AI bubble
My new documentary explores the background to this pattern and how and why I believe it will almost certainly ...
Porter & Company | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored